Cecilia Jones, Chief Financial Officer at AGIOS PHARMACEUTICALS, INC. (AGIO), sold 3,956 shares at $35.54 ($141K) on 2025-03-03, disclosed to the SEC on 2025-03-04.
Scheduled sale ($141k) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $35.54 | 594 | $21K | 15.0% |
| 2 | $35.54 | 1,681 | $60K | 42.5% |
| 3 | $35.54 | 1,681 | $60K | 42.5% |
| Total | $35.54 avg | 3,956 | $141K | 100% |
| Filing → |
| AGIO | SELL | 2026-01-02 | $79K | — | Filing → |
| AGIO | SELL | 2025-09-30 | $268K | — | Filing → |
| AGIO | SELL | 2025-06-26 | $119K | — | Filing → |